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ORIGINAL RESEARCH
Sex and Race- Ethnic Disparities in 
Door- to- CT Time in Acute Ischemic Stroke: 
The Florida Stroke Registry
Sai P. Polineni, MPH; Enmanuel J. Perez, MD, PhD; Kefeng Wang, MS; Carolina M. Gutierrez, PhD; 
Jeffrey Walker, MBA- HCM; Dianne Foster, RN, BSN, MBA; Chuanhui Dong, PhD; Negar Asdaghi , MD; 
Jose G. Romano , MD; Ralph L. Sacco , MD, MS; Tatjana Rundek, MD, PhD ; for the Florida Stroke 
Registry
BACKGROUND: Less than 40% of acute stroke patients have computed tomography (CT) imaging performed within 25 minutes 
of hospital arrival. We aimed to examine the race- ethnic and sex differences in door- to- CT (DTCT) ≤25 minutes in the FSR 
(Florida Stroke Registry).
METHODS AND RESULTS: Data were collected from 2010 to 2018 for 63 265 patients with acute ischemic stroke from the FSR 
and secondary analysis was performed on 15 877 patients with intravenous tissue plasminogen activator- treated ischemic 
stroke. Generalized estimating equation models were used to determine predictors of DTCT ≤25. DTCT ≤25 was achieved in 
56% of cases of suspected acute stroke, improving from 36% in 2010 to 72% in 2018. Women (odds ratio [OR], 0.90; 95% 
CI, 0.87– 0.93) and Black (OR, 0.88; CI, 0.84– 0.94) patients who had strokes were less likely, and Hispanic patients more 
likely (OR, 1.07; CI, 1.01– 1.14), to achieve DTCT ≤25. In a secondary analysis among intravenous tissue plasminogen activator- 
treated patients, 81% of patients achieved DTCT ≤25. In this subgroup, women were less likely to receive DTCT ≤25 (0.85, 
0.77– 0.94) whereas no significant differences were observed by race or ethnicity.
CONCLUSIONS: In the FSR, there was considerable improvement in acute stroke care metric DTCT ≤25 in 2018 in comparison 
to 2010. However, sex and race- ethnic disparities persist and require further efforts to improve performance and reduce these 
disparities.
Key Words: disparities ■ ethnicity ■ ischemic stroke ■ race ■ sex
In the United States, on average, a stroke occurs every ≈40 seconds and an individual dies of stroke every 4 minutes, making stroke a leading contributor 
of morbidity and mortality.1 Treatment with intravenous 
tissue plasminogen activator (IV tPA) is the gold stan-
dard for treatment of acute ischemic strokes (AIS).2 
The limited time window in which IV tPA is effective has 
led the American Heart Association/American Stroke 
Association (AHA/ASA) to establish the GWTG- S (Get 
With The Guidelines- Stroke) quality improvement 
program. GWTG- S was designed to improve rapid 
diagnosis of AIS and acute stroke performance met-
rics, by implementing evidence- based care.3 GWTG- S 
has also provided crucial insights into trends and dis-
parities in the quality and delivery of stroke care.4– 8
The FSR (Florida Stroke Registry) was established 
both to identify stroke disparities in the diverse patient 
population of Florida and to develop effective pro-
grams to reduce these disparities. The Florida- Puerto 
Rico Collaboration to Reduce Stroke Disparities has 
previously reported significant stroke care disparities 
in providing all appropriate interventions to patients 
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(ie, "defect- free care") among different sex and race- 
ethnic groups.9– 11 However, other acute stroke re-
porting measures, which can have a direct effect on 
primary stroke outcomes, have still not been explored 
in the FSR nor the Florida- Puerto Rico Collaboration to 
Reduce Stroke Disparities.
A door- to- computed tomography time (DTCT), 
that is, from arrival at hospital to brain CT imaging, of 
≤25 minutes is the established AHA/ASA target goal 
for patients with suspected strokes.12 Failure to meet 
this goal can result in longer door- to- needle (DTN) 
times, delayed therapeutic interventions, and worse 
outcomes.13– 15 An analysis of 1193 patients from 25 
Michigan hospitals found that although median door- 
to- imaging time from 2009 to 2012 decreased from 
21 to 18 minutes, 31.6% of their patients still experi-
enced times above 25 minutes, with significant vari-
ation between hospitals and resultant increases in 
DTN.15 Findings such as these necessitate the con-
tinual need to assess and address such disparities 
both longitudinally and across various populations.
In the process of stroke care from onset, emergency 
services response, arrival to a hospital setting, and inter-
ventions, CT imaging occurs after arrival and before inter-
vention. Though delays in CT imaging occur, disparities 
in timing of imaging are not frequently studied. However, 
time from door to CT is an actionable step for improve-
ment within the hospital process of stroke care. Disparities 
in DTCT can be eliminated by implementing protocols that 
improve timing of DTCT by rapid transport from the emer-
gency department to the CT suite and by improving prox-
imity of the CT to the emergency department.
Prior work has shown that participation in GWTG- S, 
including duration of participation, improves stroke 
outcomes through systematic data collecting that 
standardizes the hospital protocols and improves sys-
tems of care, provides more complete data extraction, 
improves data quality, and reduces disparities by sub-
sequent analysis and education.16– 19 Therefore, the 
main factors that affect DTCT time are mostly depen-
dent on hospital characteristics (eg, size, type) and 
readiness to treat patients with strokes, especially 
during OFF hours, as well as on prehospital factors 
(eg, mode of arrival) and individual level factors (eg, 
insurance). Longer participation in the GWTG- S pro-
gram may mitigate some of these disparities.
The known disparities in stroke interventions (ie, 
DTN) and outcomes occur independently and add 
to disparities that persist from prehospital systems of 
care.4,6,9,13,14,20– 27 Although there were few race- ethnic 
disparities identified in DTN ≤60 or ≤45 minutes in this 
study population, female patients were significantly 
less likely than male patients to receive thrombolytic 
therapy in accordance with AHA/ASA Target: Stroke 
Phase II recommendations.10,12 It is currently not well 
established whether there are sex and/or race- ethnic 
disparities in achieving DTCT ≤25.
The primary aim of this study is to assess whether 
sex and/or race- ethnic disparities in DTCT exist in a 
diverse AIS Florida population and, if such disparities 
are identified, to assess whether they depend on pre-
hospital factors (eg, mode of arrival, insurance, etc), 
hospital characteristics, and/or individual- level factors. 
The secondary aim is to explore whether there are sim-
ilar disparities in patients who received IV tPA within 
4.5 hours of stroke onset, as prior work in this patient 
population identified sex and race- ethnic differences in 
thrombolytic therapy.9,10
METHODS
The study data and materials were obtained from 
hospitals via data use agreements that prohibit them 
being shared. Instead, we offer the opportunity to 
CLINICAL PERSPECTIVE
What Is New?
• Female and Black patients with acute ischemic 
stroke were less likely to achieve door- to- 
computed tomography time within 25 minutes 
(DTCT ≤25) relative to male and White patients, 
respectively.
• Hispanic patients, however, are more likely 
to achieve DTCT ≤25 in comparison to White 
patients.
• In the subgroup of patients with acute ischemic 
stroke who receive intravenous tissue plasmi-
nogen activator, sex but not race- ethnic dis-
parity in DTCT ≤25 was present; all sex and 
race- ethnic groups have seen improvements 
from 2010 to 2018.
What Are the Clinical Implications?
• Sex and race- ethnic disparities in DTCT after 
acute ischemic stroke continue to persist, de-
spite improvements in the proportion of patients 
achieving the American Heart Association/
American Stroke Association recommended 
guideline of DTCT ≤25.
• The causes of sex disparities in DTCT may dif-
fer from causes of race- ethnic disparities, and 
further research is needed to identify them and 
reduce observed disparities.
Nonstandard Abbreviations and Acronyms
DTCT ≤25 door- to- computed tomography time 
within 25  minutes
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propose studies with the data, with methods and 
analyses performed by the FSR Biostatistics Core. 
The FSR includes 93 Florida hospitals (out of 124 
hospitals that treat stroke in Florida) that participate 
in GWTG- S. The FSR includes both prospective and 
retrospective hospital- collected GWTG- S data on 
patients with a primary diagnosis of ischemic stroke, 
transient ischemic attack, subarachnoid hemorrhage, 
intracerebral hemorrhage, and stroke not otherwise 
specified. A total of 164  173 patients with AIS from 
Florida were enrolled from January 2010 through 
December 2018. Exclusion criteria from GWTG- S 
Patient Management Tool for % DTCT ≤25 was used: 
age under 18 years, stroke occurred as inpatient, ar-
rival at the hospital over 24 hours from stroke onset, 
symptoms resolved upon arrival, any date/time fields 
missing or unknown, negative calculated time differ-
ence, initial National Institute of Health Stroke total 
score of zero, current participation in a clinical trial, 
and uncompleted elective carotid intervention or 
brain imaging. The total sample included 63 265 AIS 
records.
Data Source
Data were originally collected as part of the AHA/ASA 
GWTG- S program, a voluntary national registry with 
the purpose of improving stroke care. For participa-
tion in the FSR, each participating center received in-
stitutional approval to enroll cases in the FSR with an 
amendment made to the GWTG- S agreement grant-
ing the University of Miami Miller School of Medicine 
access to limited GWTG- S data. Complete data col-
lections methods have been previously reported.9 
Data collection was approved by each participating 
institutional review board— without requiring individual 
patient consent under the common rule or a waiver 
of authorization and exemption— and this study was 
approved by the University of Miami Miller School of 
Medicine institutional review board.
Outcome Measure
The main outcome measure examined in this study is 
DTCT ≤25 minutes upon arrival to hospital for all pa-
tients suspected of AIS. Our analysis includes all di-
agnosed AISs. Race- ethnicity (Non- Hispanic White, 
Non- Hispanic Black, and Hispanic) was self- reported. 
The term "Hispanic" was specified by the GWTG- S 
Patient Management and Data Collection Tool and 
represents "Hispanic or Latino" patients.28 Additional 
analyses were performed by arrival time after stroke 
onset (0– 6 hours versus 6– 24 hours) and by "ON" (ie, 
working) and "OFF" (ie, nonworking) hours with OFF 
hours being Monday through Friday from 6 pm to 7 am, 
along with full days on Saturdays, Sundays, and gov-
ernment holidays.
Statistical Analysis
Univariable descriptive and multivariable analyses were 
conducted using SAS, version 9.3. In the univariable 
analysis of patient- and hospital- level characteristics, 
continuous variables were summarized as means with 
SD and categorical variables were presented as fre-
quencies with percentages. The Student t test and the 
Pearson χ2 test were used to compare the differences 
for continuous and categorical variables, respectively. 
To account for within- hospital clustering, multilevel mul-
tivariable logistic regression with generalized estimat-
ing equations approach was performed to examine the 
factors associated with faster DTCT time and the race/
ethnicity and sex disparities in DTCT time. For gener-
alized estimating equations, the exponential family of 
distribution, logit link function, and compound sym-
metry covariance structure were used. To account for 
the contribution of the patient- level and hospital- level 
characteristics in explaining the aforementioned dis-
parities, 3 sequential models were constructed to in-
clude patient- level and hospital- level covariates. These 
covariates are prespecified, and models sequentially 
follow from our primary interest (sex and race- ethnic 
disparity)— to first determine disparities independent of 
individual levels of stroke risk— and progress to include 
hospital characteristics and systems of care. Model 1 
was adjusted for age and either race/ethnicity or sex. 
Model 2 was adjusted for covariates included in Model 
1 and health insurance status, mode of arrival and 
hospital- level factors including number of beds, years 
in GWTG- S, and academic status. Model 3 included 
Model 2 with additional adjustments for vascular risk 
factors (current smoker, hypertension, diabetes mel-
litus, dyslipidemia), and past medical history of atrial 
fibrillation, coronary artery disease/prior MI, and pre-
vious stroke/TIA. The effect modifications of working/
nonworking hours and arrival time after onset of stroke 
(within 0– 6 hours/6– 24 hours) were tested in Model 3 
and stratified analyses were performed.
RESULTS
The baseline patient and hospital characteristics are 
detailed in Table 1. The median DTCT time was 22 min-
utes (interquartile range [IQR]=34) and DTCT ≤25 was 
achieved in 56% of all patients. Overall median DTCT 
time was 23 minutes (IQR=36) in women and 21 min-
utes (IQR=33) in men. DTCT time was lowest in White 
patients, 21  minutes (IQR=32); followed by Hispanic 
patients, 22  minutes (IQR=32); and Black patients, 
23 minutes (IQR=37).
In unadjusted analysis of acute suspected strokes 
(Table  1), patients with DTCT ≤25 were significantly 
older (mean age, 73 versus 71) and more likely to 
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Table 1. Patient- and Hospital- Level Characteristics of All Acute Ischemic Stroke Patients Within the Florida Stroke 
Registry Cohort (2010– 2018)
Patient Characteristics All (N=63 265) Door to CT ≤25 min (N=35 312) Door to CT >25 min (N=27 953)
Age (y), mean±SD 72±14 73±14 71±15
Sex, n (%)
Men 31 794 (50) 18 070 (51) 13 724 (49)
Women 31 471 (50) 17 242 (49) 14 229 (51)
Race/ethnicity, n (%)
White 42 704 (68) 24 100 (68) 18 604 (67)
Black 11 186 (18) 5833 (17) 5353 (19)
Hispanic 9375 (15) 5379 (15) 3996 (14)
Region, n (%)
South FL 26 092 (41) 16 093 (46) 9999 (36)
West Central FL 18 610 (29) 9420 (27) 9190 (33)
East Central FL 11 537 (18) 6051 (17) 5486 (20)
North FL and Panhandle 7026 (11) 3748 (11) 3278 (12)
Vascular risk factor, n (%)
Current smoker 9839 (16) 5251 (15) 4588 (16)
Hypertension 44 274 (70) 24 511 (69) 19 763 (71)
Diabetes mellitus 18 355 (29) 9649 (27) 8706 (31)
Dyslipidemia 26 182 (41) 14 475 (41) 11 707 (42)
Medical history, n (%)
Atrial fibrillation/flutter 14 850 (23) 9134 (26) 5716 (20)
Coronary artery disease/prior 
myocardial infarction
14 577 (23) 7991 (23) 6586 (24)
Previous stroke/transient ischemic 
attack
18 104 (29) 9773 (28) 8331 (30)
Insurance status, n (%)
Private* 22 187 (35) 12 472 (35) 9715 (35)
Medicare 21 804 (34) 11 641 (33) 10 163 (36)
Uninsured† 5967 (9) 2915 (8) 3052 (11)
Unknown 13 307 (21) 8284 (23) 5023 (18)
National Institute of Health Stroke Score, n (%)
≤5 26 100 (41) 13 361 (38) 12 739 (46)
6– 15 18 346 (29) 12 429 (35) 5917 (21)
≥16 11 435 (18) 8150 (23) 3285 (12)
Missing 7384 (12) 1372 (4) 6012 (22)
Arrival mode, n (%)
EMS 44 633 (71) 27 680 (78) 16 953 (61)
Non- EMS 16 040 (25) 6426 (18) 9614 (34)
Missing/unknown 2592 (4) 1206 (3) 1386 (5)
Ambulation status, n (%)
Independent 22 525 (36) 12 289 (35) 10 236 (37)
Unable/with assistance 24 256 (38) 13 949 (40) 10 307 (37)
Missing/ND 16 484 (26) 9074 (26) 7410 (27)
Hospital characteristics
Hospital size‡, n (%)
Low (<250 beds) 20 668 (33) 12 229 (35) 8439 (30)
Medium (250– 450 beds) 20 905 (33) 12 079 (34) 8826 (32)
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>25  minutes. Black patients with stroke had a lower 
percentage achieving DTCT ≤25, 52%, versus 56% 
for White patients and 57% for Hispanic patients. By 
geographic region, South Florida had the highest 
likelihood of DTCT ≤25, 62% versus 52% for all other 
Florida regions. Significant factors associated with 
DTCT >25 minutes were diabetes mellitus and a his-
tory of coronary artery disease or myocardial infarc-
tion (Table S1). Patients who received DTCT ≤25 had a 
larger proportion of severe strokes (National Institute of 
Health Stroke Score >5) and were more likely to arrive 
by emergency medical services (EMS). Arrival by EMS 
resulted in 61% of patients receiving DTCT ≤25 in com-
parison to 40% of patients not arriving by EMS.
Table  2 shows adjusted odds ratios for receiving 
DTCT ≤25 by sex, race/ethnicity, ON/OFF hours, and 
arrival time from onset of symptoms. Overall, women 
were less likely to receive DTCT ≤25 (55% compared 
with 57% of men). In fully adjusted models (ie, adjust-
ing for both patient- and hospital- level characteristics), 
women were also less likely to receive DTCT ≤25 when 
compared with men (odds ratio [OR], 0.90; 95% CI, 
0.87– 0.93).
In the fully adjusted model (Table 2), Black patients 
were less likely to achieve DTCT ≤25 than White pa-
tients (OR, 0.88; 95% CI, 0.84– 0.94), whereas Hispanic 
patients showed increased odds (OR, 1.07; 95% CI, 
1.01– 1.14). Stratification by admission time revealed 
that Black patients, when compared with White pa-
tients, experienced lower odds of DTCT ≤25 on both 
ON (OR, 0.89; 95% CI, 0.83– 0.96) and OFF (OR, 0.88; 
95% CI, 0.82– 0.95) hours whereas Hispanic patients 
experienced higher odds only during OFF (OR, 1.09; 
95% CI, 1.01– 1.19) hours. When stratifying patients by 
arrival time at hospital after onset of stroke symptoms, 
women showed decreased odds of DTCT ≤25 in both 
the 0 to 6 hours (OR, 0.91; 95% CI, 0.87– 0.95) and 6 
to 24 hours (OR, 0.88; 95% CI, 0.84– 0.93) subgroups 
(Table 2). Although there were no differences in odds of 
DTCT ≤25 by race- ethnic group when patients arrived 
within 6 hours of symptom onset, arrival 6 to 24 hours 
after symptom onset led to Black patients experienc-
ing lower odds (OR, 0.88; 95% CI, 0.80– 0.97) and 
Hispanic patients experiencing higher odds (OR, 1.13; 
95% CI, 1.02– 1.26) of DTCT ≤25 compared with White 
patients. No significant effect modification between 
Patient Characteristics All (N=63 265) Door to CT ≤25 min (N=35 312) Door to CT >25 min (N=27 953)
Academic status, n (%)
Teaching hospital 21 789 (34) 11 645 (33) 10 144 (36)
Nonteaching hospital 41 476 (66) 23 667 (67) 17 809 (64)
Years in Get With The Guidelines- Stroke§, n (%)
Low 18 867 (30) 10 910 (31) 7957 (28)
Medium 22 038 (35) 11 418 (32) 10 620 (38)
High 22 360 (35) 12 984 (37) 9376 (34)
All P values are <0.01. AF atrial fibrillation; CAD, coronary artery disease; EMS indicates emergency medical services; FL, Florida; and ND, not determined.
*Includes private insurance, Veterans Affairs, and other.
†Includes Medicaid, self- pay, and no insurance.
‡Determined by licensed number of beds.
§Determined by tercile. Each terciles’ mean (SD) value is: low=6.4 (2.7), medium=11.7 (0.5), high=13.9 (1.2).
Table 1. Continued
Table 2. Adjusted Odds Ratio and 95% CI for Race- Ethnic and Sex Differences in Door- to- CT Time Within 25 Minutes
White Black Hispanic Male Female
No. eligible patients 42 704 11 186 9375 31 794 31 471
% DTCT ≤25 min 56.4 52.2 57.4 56.8 54.8
Model 1 [REF] 0.83 (0.79– 0.89) 1.01 (0.95– 1.08) [REF] 0.92 (0.89– 0.95)
Model 2 [REF] 0.86 (0.81– 0.91) 1.05 (0.98– 1.12) [REF] 0.91 (0.88– 0.93)
Model 3 [REF] 0.88 (0.84– 0.94) 1.07 (1.01– 1.14) [REF] 0.90 (0.87– 0.93)
ON hours* [REF] 0.89 (0.83– 0.96) 1.05 (0.94– 1.17) [REF] 0.92 (0.88– 0.96)
OFF hours* [REF] 0.88 (0.82– 0.95) 1.09 (1.01– 1.19) [REF] 0.88 (0.84– 0.92)
Arrival Time from Onset: 0– 6 h* [REF] 0.94 (0.87– 1.01) 1.04 (0.96– 1.11) [REF] 0.91 (0.87– 0.95)
Arrival Time from Onset: 6– 24 h* [REF] 0.88 (0.80– 0.97) 1.13 (1.02– 1.26) [REF] 0.88 (0.84– 0.93)
Model 1: adjusted for age plus either race/ethnicity or sex. Model 2: includes Model 1 with additional adjustments for health insurance status, mode of arrival, 
and hospital- level factors including number of beds, years in Get With The Guidelines- Stroke, and academic status. Model 3: includes Model 2 with additional 
adjustments for vascular risk factors (current smoker, hypertension, diabetes mellitus, dyslipidemia), and past medical history (atrial fibrillation, coronary artery 
disease/prior myocardial infarction, and previous stroke/transient ischemic attack). DTCT indicates door- to- computed tomography time.
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sex and race/ethnicity in Model 3 was noted (P=0.13) 
(Table S2).
Examination of temporal trends from 2010 to 2018 
revealed median DTCT time has improved from 35 to 
13 minutes and DTCT ≤25 improved from 36 to 72%. 
Proportion of DTCT ≤25 showed a statistically signifi-
cant temporal increase (P<0.0001) for both men and 
women and across all race- ethnic groups (Figure 1A 
and 1B). Despite this improvement, women were con-
sistently less likely to get brain imaging performed within 
25 minutes after hospital arrival. The greatest improve-
ment in DTCT ≤25 was observed in Hispanic patients 
(33%– 75%) and the least improvement was observed 
in Black patients (34%– 69%); White patients improved 
from 38% to 73%. Examination of geographic trends in 
DTCT ≤25 showed all regions steadily improved over 
time (Figure 1C). Improvement was greatest in the East 
Central region (25– 70%), followed by South Florida 
(42%– 77%), North Florida and the Panhandle (38%– 
71%), and West Central Florida (34%– 66%).
In a secondary analysis examining DTCT time in pa-
tients treated by IV tPA within 4.5 hours of stroke (25%; 
15 877 of 63 265), 81% of patients received DTCT ≤25 
when compared with 56% in the overall population. 
Similar temporal trends in DTCT ≤25 akin to the total 
cohort were observed across all sex and race- ethnic 
groups, as well as by region (Figure 2). Within this sub-
set of patients, women were less likely to achieve DTCT 
≤25, (OR, 0.85; 95% CI, 0.77– 0.94) when compared 
with men (Table  3). Stratification by ON/OFF hours, 
showed similar results with women being less likely 
to achieve DTCT ≤25 in nonworking hours (OR, 0.85; 
95% CI, 0.73– 0.97), and trending toward similar results 
in working hours (OR, 0.86; 95% CI, 0.75– 1.00) hours. 
There were no significant differences in the likelihood of 
DTCT ≤25 between race- ethnic groups in this second-
ary analysis, even when stratified by ON/OFF hours.
DISCUSSION
Few studies have examined race- ethnic differences 
in secondary stroke care metrics, such as DTCT time, 
despite well- established disparities in acute stroke 
care.5,15,25 Our current study examining disparities in 
DTCT in the FSR reveals significant disparities in re-
ceiving DTCT ≤25 that affect female and Black patients 
who had strokes, despite notable improvements in this 
acute stroke care metric from 2010 to 2018. These dis-
parities in DTCT ≤25 persist during both working and 
nonworking hours. Sex disparities persist regardless 
of arrival time whereas racial disparities existed only 
in patients who arrived late, 6 to 24 hours after stroke 
onset. Interestingly, Hispanic stroke patients showed 
increased odds of achieving DTCT ≤25 compared with 
White patients, a finding not seen in our DTN analysis10 
and door- to- imaging times in the national GWTG- S.5
In our prior work, we reported that Floridian and 
Puerto Rican Hispanic patients had the lowest median 
DTN times but no statistically significant difference in 
odds of achieving DTN ≤60  minutes compared with 
White patients.10 Our study shows no race- ethnic differ-
ence in DTCT in the subgroup of patients who received 
IV tPA within 4.5  hours from stroke onset. This sug-
gests the lack of DTN disparities by race/ethnicity may 
be secondary to equitable achievement of DTCT in the 
subgroup treated with IV tPA. However, in the overall AIS 
population, which includes patients who do not receive 
IV tPA, there is a statistically significant increase in DTCT 
≤25 among Hispanic patients and a decrease among 
Black patients. The improved DTCT among Hispanic pa-
tients has been noted in other studies and may be the 
Figure 1. % DTCT ≤25 minutes over time across sex, race- 
ethnicity, and region.
The percentage of patients with acute ischemic stroke achieving 
DTCT ≤25 minutes increased over time in all (A) sex, (B) race- 
ethnic, and (C) regional subgroups from 2010 to 2018. DTCT 
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result of socioeconomic factors, social support, interac-
tion and connectivity, and patient and family knowledge 
about stroke, access to care, and baseline prevalence 
rates, among other factors that were not collected in the 
GWTG- S protocol and not included in this analysis.17,29,30 
Conversely, such factors may have contributed to the de-
creased achievement of DTCT ≤25 among Black patients 
in addition to racism, discrimination, and implicit bias.
Lower likelihood of DTCT ≤25 for non- White pa-
tients has been previously reported in a study of 
GWTG patients from 2003 to 2009.5 Specifically, Black 
patients are less likely to receive DTCT ≤25 when com-
pared with White patients, even if the quality of hospi-
tal care is relatively similar.25 Black patients have high 
rates of diabetes mellitus and the lowest rates of ar-
rival by EMS, both of which are known to contribute 
to increased DTCT time.4,5,23,27,29 Interestingly, those 
race- ethnic disparities do not appear in the subgroup 
of patients treated with IV tPA. However, in the general 
cohort with AIS, the persistence of race- ethnic dispar-
ities despite adjustment for demographic, clinical, and 
hospital characteristics suggests the presence of ei-
ther unaccounted clinical and hospital characteristics 
or the influence of prehospital factors, social determi-
nants of health, and other sociocultural and patient- 
level factors that have been linked to DTN time10,26,31 but 
not yet clearly for DTCT time. Black patients also tend 
to be younger while still experiencing the highest rate 
of previous stroke or TIA, making symptom identifica-
tion more difficult. Similarly, lower knowledge of stroke 
symptoms and treatment in Black communities may 
contribute to delays in calling 911, arrival to the hos-
pital, and arrival outside the tPA treatment window.32 
However, although health literacy may contribute to 
delays in stroke detection outside the hospital, their in-
fluence on DTCT is poorly understood and needs to be 
considered amid a larger picture of physician– patient 
communication, language barriers, reliance on patient 
or family history for stroke identification, implicit biases, 
and other factors.
Our study shows that significant disparities in DTCT 
time persist for women within the subgroup treated 
with IV tPA, regardless of working or nonworking 
hours. These disparities parallel those identified in 
DTN time in the same patient population.10 It has been 
recognized that early stroke symptoms in women pa-
tients who are eligible for IV tPA may not be as quickly 
recognized or may differ when compared with early 
stroke symptoms in men, leading to a sex difference in 
DTCT, potentially explaining some of the sex difference 
in DTCT ≤25 seen in the subgroup treated with IV- tPA 
.33,34 Given that early identification of symptoms and 
treatment with IV tPA is associated with favorable out-
comes, this sex disparity in DTCT ≤25 may manifest in 
subsequent sex disparities in multiple poststroke out-
comes.2,3 Such disparities lead to decreased defect- 
free care for women.9,35 This "sex gap" in the treatment 
of acute stroke has been previously established and 
resulted in multiple meta- analyses confirming such sex 
differences in quality of care and stroke outcomes.22,35 
Despite this well- established disparity, women con-
tinue to receive a lower standard of care when com-
pared with men. Our study reveals that the absolute 
difference in proportion of men versus women who 
achieve DTCT ≤25 has changed from 0.8 in 2010 to 
1.5 in 2018, with significant yearly variation (minimum 
Figure 2. % DTCT ≤25  minutes in subgroup treated with 
tPA over time across sex, race- ethnicity, and region.
Among patients with acute ischemic stroke who received 
intravenous tissue plasminogen activator treatment, the 
percentage achieving DTCT ≤25 minutes increased over time in 
all (A) sex, (B) race- ethnic, and (C) regional subgroups from 2010 
to 2018. DTCT indicates door- to- computed tomography time; 
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of 0.8, maximum of 2.4) and with men achieving the 
higher proportion since 2011.
Overall, DTCT times and the percentage of eligible 
patients meeting the DTCT ≤25 target showed steady 
annual improvements from 2010 to 2018. A comprehen-
sive review examining reasons for delay times in acute 
stroke care showed that across 23 population groups 
there was ≈6 min/year in improvements in DTCT.21 In 
our study, we observed a decline in DTCT from a me-
dian of 35 minutes to 13 minutes, or 2.75 minutes/year, 
and analogous improvement in DTCT ≤25 from 36% to 
72%. Although outcome is not yet optimal, it is compa-
rable to previously reported findings and underscores 
the considerable progress made in this arena.4,5,8,29 
Furthermore, the improvement in DTCT from 2010 to 
2018 is likely secondary to a combination of factors: 
increased education and awareness among patients, 
families, and staff; increased availability of CT imaging; 
increased numbers of and experience within primary 
stroke center hospitals; and national incentives for qual-
ity improvement in conjunction with the AHA GWTG- S 
initiative and stroke quality improvement recognition 
awards.16– 19 It is important to note that these annual 
improvements in the DTCT ≤25 occur both before and 
following the implementation of new guidelines for door- 
to- imaging time in acute reperfusion strategies in 2015.2 
Determination of the impact of these guidelines on the 
annualized percent change in the improving DTCT ≤25 
metric will require test of trend analysis in future work.
AHA/ASA recommends the time of arrival to treatment 
with recombinant tPA to be <60 minutes.2,20 In prior work 
conducted on our cohort for the years 2010 to 2015, few 
race- ethnic differences in DTN times were observed, 
whereas significant sex disparities in DTN times were 
identified.10 Sex disparities in received care were evident 
in both DTCT and DTN times, indicating that disparities in 
DTN times resulted at least in part from disparities in DTCT.
The prior analysis of DTN time in this cohort also 
revealed significant geographic variation, with South 
Florida having the greatest proportion of patients 
(50%) achieving DTN ≤60 and West Central Florida 
having the lowest (28%). Our work also identified re-
gional variations in DTCT time, though, interestingly, 
the geographic variation in DTCT did not correlate well 
with that seen in DTN times. All regions showed simi-
lar annual improvements in the proportion of patients 
achieving DTCT ≤25 from 2010 to 2018.
Analysis of a national cohort showed that longer 
delay in DTCT was associated with lower likelihood of 
receiving IV tPA among eligible patients.36 Moreover, 
many of the patient and hospital characteristics con-
tributing to decreased likelihood of DTCT ≤25 in our 
study, such as female sex, non- White race, diabetes 
mellitus, prior stroke, and not arriving by EMS, were 
also associated with decreased likelihood of treat-
ment with IV tPA, even among eligible patients, and 
have been noted in national studies of disparities in 
tPA use.24,37 In addition, improvements in DTCT are not 
necessarily indicative of improved DTN times. Although 
it is currently suggested to initiate IV tPA in the CT suite, 
variations in imaging- to- needle times also contribute to 
increased DTN times.15
Our FSR contains 164  173 cases of suspected 
strokes across 93 hospitals throughout Florida, out of 
124 Florida hospitals that treat stroke. The accuracy 
and reliability of the GWTG- S data has been validated 
by a national audit.38 The generalizability of the data 
has been studied and shown to be representative of 
the AIS Medicare- aged population— who constitute 
most, but not all, of our study cohort— despite substan-
tial differences between GWTG- S and non- GWTG- S 
hospitals.39 The GWTG- S hospitals tend to be large, 
urban teaching hospitals in proportions greater than 
the nationally proportionate value.39 Though our study 
includes a diverse patient population, that same diver-
sity may limit generalizability of study findings to re-
gional locations with similar race- ethnic breakdown. 
Furthermore, given the noted differences within and 
Table 3. Door- to- CT Time ≤25 Minutes in Patients Treated With IV- tPA by Sex and Race/Ethnicity
White Black Hispanic Male Female
No. eligible patients 10 768 2619 2490 8061 7816
% DTCT ≤25 min 81.0 80.1 83.2 82.1 80.3
Model 1, OR and 95% CI [REF] 0.99 (0.88– 1.13) 0.99 (0.81– 1.20) [REF] 0.84 (0.78– 0.90)
Model 2, OR and 95% CI [REF] 1.01 (0.89– 1.15) 1.03 (0.84– 1.25) [REF] 0.84 (0.78– 0.90)
Model 3, OR and 95% CI [REF] 1.03 (0.88– 1.19) 1.06 (0.84– 1.33) [REF] 0.85 (0.77– 0.94)
ON hours*, OR and 95% CI [REF] 1.09 (0.87– 1.38) 0.91 (0.70– 1.19) [REF] 0.86 (0.75– 1.00)
OFF hours*, OR and 95% CI [REF] 0.99 (0.80– 1.23) 1.26 (0.94– 1.67) [REF] 0.85 (0.73– 0.97)
All secondary analysis models were run restricting arrival time from onset of stroke to 4.5 hours. Model 1: adjusted for age plus either race/ethnicity or sex. 
Model 2: includes Model 1 with additional adjustments for health insurance status, mode of arrival, and hospital- level factors including number of beds, years 
in Get With The Guidelines- Stroke, and academic status. Model 3: includes Model 2 with additional adjustments for vascular risk factors (current smoker, 
hypertension, diabetes mellitus, dyslipidemia), and past medical history (atrial fibrillation, coronary artery disease/prior myocardial infarction, and previous 
stroke/transient ischemic attack). DTCT indicates door- to- computed tomography time; and IV- tPA, intravenous tissue plasminogen activator.
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between Hispanic subgroups (eg, Cuban, Puerto 
Rican, Dominicans, Mexican, South/Central American), 
these findings in our predominantly Cuban and Puerto 
Rican population should be investigated in other 
Hispanic subgroups, given intra- and intergroup dif-
ferences in immigration status, socioeconomic status, 
cultural differences, perceptions and biases, and given 
geographic variation in systems of care and social de-
terminants of health.30,40,41 Discrepancies in DTCT re-
porting, where the definition varies between "initiation 
of imaging," "completion of imaging," or "interpretation 
of imaging," can also contribute to variations in DTCT 
times and limitations of generalizability across studies. 
However, we are among the few studies to examine 
the predictors of DTCT and improvements in DTCT 
over time in a culturally and racially- ethnically diverse 
cohort. Implementation of best practice interventions 
advocated by the AHA Target Stroke Initiative have 
been shown to result in substantial decreases in DTCT 
and DTN times and should be considered when at-
tempting to ameliorate identified disparities and im-
prove DTCT times in general.42,43 Future studies should 
be performed for identification of factors that precede 
brain imaging and lead to race- ethnic and sex DTCT 
time disparities, to address the effect of these ob-
served disparities in DTCT time on stroke care, and to 
evaluate the causal effect that DTCT disparities alone 
have in contributing to stroke morbidity and mortality.
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Table S1. Factors Associated with Door-to-CT (DTCT) time ≤25 min. 
 
Factors DTCT ≤ 25 vs DTCT > 25 
Age  
     65-79 (vs 18-64) 1.10 (1.04,1.16) 
     >80 (vs 18-64) 1.03 (0.95,1.11) 
NIHSS  
     6-15 (vs <5) 1.91 (1.71,2.13) 
     >16 (vs <5) 2.13 (1.83,2.48) 
Current Smoker  
     Yes (vs No) 1.00 (0.95,1.06) 
Hypertension  
     Yes (vs No) 0.98 (0.93,1.03) 
Diabetes Mellitus  
     Yes (vs No) 0.89 (0.85,0.94) 
Dyslipidemia  
     Yes (vs No) 1.01 (0.96,1.06) 
Prior CAD/MI  
     Yes (vs No) 0.91 (0.86,0.96) 
Prior stroke/TIA  
     Yes (vs No) 0.95 (0.88,1.02) 
EMS Arrival    
     Yes (vs No) 2.24 (1.99, 2.52) 
 
Fully adjusted model includes age, race/ethnicity, sex, insurance status, smoking status, 
hypertension, diabetes mellitus, CAD/prior MI, prior stroke /TIA, dyslipidemia, atrial 
fibrillation, peripheral vascular disease, history of stroke or TIA & ambulation status at 
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Table S2. Study Cohort Stratified by Sex and Race-Ethnicity. 
 White Black Hispanic 
Male 21,684 5,439 4,671 
Door to CT < 25 min 12,470 2,878 2,722 
Door to CT > 25 min 9,214 2,561 1,949 
Female 21,020 5,747 4,704 
Door to CT < 25 min 11,630 2,955 2,657 
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